Global Gastrointestinal Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Description

The Gastrointestinal market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Gastrointestinal size is estimated to be USD 36520 million in 2026 from USD 35430 million in 2020, with a change XX% between 2020 and 2021. The global Gastrointestinal market size is expected to grow at a CAGR of 0.8% for the next five years.

Market segmentation
Gastrointestinal market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Prescription Gastrointestinal Drug
    OTC Gastrointestinal Drug

Market segment by Application, can be divided into
    Chronic Gastritis
    Functional Dyspepsia
    Peptic Ulcer
    Acute Gastroenteritis
    Others

Market segment by players, this report covers
    AstraZenec
    Sanofi
    Bayer
    Pfizer
    GlaxoSmithKline
    Teva
    Zeria（Tillotts）
    Perrigo
    Boehringer Ingelheim
    Purdue Pharma
    C.B. Fleet
    Abbott
    Jiangzhong
    Xian-Janssen

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Gastrointestinal product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gastrointestinal, with revenue, gross margin and global market share of Gastrointestinal from 2019 to 2021.
Chapter 3, the Gastrointestinal competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Gastrointestinal market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Gastrointestinal research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gastrointestinal
    1.2 Classification of Gastrointestinal by Type
        1.2.1 Overview: Global Gastrointestinal Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Gastrointestinal Revenue Market Share by Type in 2020
        1.2.3 Prescription Gastrointestinal Drug
        1.2.4 OTC Gastrointestinal Drug
    1.3 Global Gastrointestinal Market by Application
        1.3.1 Overview: Global Gastrointestinal Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Chronic Gastritis
        1.3.3 Functional Dyspepsia
        1.3.4 Peptic Ulcer
        1.3.5 Acute Gastroenteritis
        1.3.6 Others
    1.4 Global Gastrointestinal Market Size & Forecast
    1.5 Global Gastrointestinal Market Size and Forecast by Region
        1.5.1 Global Gastrointestinal Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Gastrointestinal Market Size by Region, (2016-2021)
        1.5.3 North America Gastrointestinal Market Size and Prospect (2016-2026)
        1.5.4 Europe Gastrointestinal Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Gastrointestinal Market Size and Prospect (2016-2026)
        1.5.6 South America Gastrointestinal Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Gastrointestinal Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Gastrointestinal Market Drivers
        1.6.2 Gastrointestinal Market Restraints
        1.6.3 Gastrointestinal Trends Analysis

2 Company Profiles
    2.1 AstraZenec
        2.1.1 AstraZenec Details
        2.1.2 AstraZenec Major Business
        2.1.3 AstraZenec Gastrointestinal Product and Solutions
        2.1.4 AstraZenec Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 AstraZenec Recent Developments and Future Plans
    2.2 Sanofi
        2.2.1 Sanofi Details
        2.2.2 Sanofi Major Business
        2.2.3 Sanofi Gastrointestinal Product and Solutions
        2.2.4 Sanofi Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Sanofi Recent Developments and Future Plans
    2.3 Bayer
        2.3.1 Bayer Details
        2.3.2 Bayer Major Business
        2.3.3 Bayer Gastrointestinal Product and Solutions
        2.3.4 Bayer Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Bayer Recent Developments and Future Plans
    2.4 Pfizer
        2.4.1 Pfizer Details
        2.4.2 Pfizer Major Business
        2.4.3 Pfizer Gastrointestinal Product and Solutions
        2.4.4 Pfizer Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Pfizer Recent Developments and Future Plans
    2.5 GlaxoSmithKline
        2.5.1 GlaxoSmithKline Details
        2.5.2 GlaxoSmithKline Major Business
        2.5.3 GlaxoSmithKline Gastrointestinal Product and Solutions
        2.5.4 GlaxoSmithKline Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 GlaxoSmithKline Recent Developments and Future Plans
    2.6 Teva
        2.6.1 Teva Details
        2.6.2 Teva Major Business
        2.6.3 Teva Gastrointestinal Product and Solutions
        2.6.4 Teva Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Teva Recent Developments and Future Plans
    2.7 Zeria（Tillotts）
        2.7.1 Zeria（Tillotts） Details
        2.7.2 Zeria（Tillotts） Major Business
        2.7.3 Zeria（Tillotts） Gastrointestinal Product and Solutions
        2.7.4 Zeria（Tillotts） Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Zeria（Tillotts） Recent Developments and Future Plans
    2.8 Perrigo
        2.8.1 Perrigo Details
        2.8.2 Perrigo Major Business
        2.8.3 Perrigo Gastrointestinal Product and Solutions
        2.8.4 Perrigo Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Perrigo Recent Developments and Future Plans
    2.9 Boehringer Ingelheim
        2.9.1 Boehringer Ingelheim Details
        2.9.2 Boehringer Ingelheim Major Business
        2.9.3 Boehringer Ingelheim Gastrointestinal Product and Solutions
        2.9.4 Boehringer Ingelheim Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.10 Purdue Pharma
        2.10.1 Purdue Pharma Details
        2.10.2 Purdue Pharma Major Business
        2.10.3 Purdue Pharma Gastrointestinal Product and Solutions
        2.10.4 Purdue Pharma Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Purdue Pharma Recent Developments and Future Plans
    2.11 C.B. Fleet
        2.11.1 C.B. Fleet Details
        2.11.2 C.B. Fleet Major Business
        2.11.3 C.B. Fleet Gastrointestinal Product and Solutions
        2.11.4 C.B. Fleet Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 C.B. Fleet Recent Developments and Future Plans
    2.12 Abbott
        2.12.1 Abbott Details
        2.12.2 Abbott Major Business
        2.12.3 Abbott Gastrointestinal Product and Solutions
        2.12.4 Abbott Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Abbott Recent Developments and Future Plans
    2.13 Jiangzhong
        2.13.1 Jiangzhong Details
        2.13.2 Jiangzhong Major Business
        2.13.3 Jiangzhong Gastrointestinal Product and Solutions
        2.13.4 Jiangzhong Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Jiangzhong Recent Developments and Future Plans
    2.14 Xian-Janssen
        2.14.1 Xian-Janssen Details
        2.14.2 Xian-Janssen Major Business
        2.14.3 Xian-Janssen Gastrointestinal Product and Solutions
        2.14.4 Xian-Janssen Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Xian-Janssen Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gastrointestinal Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Gastrointestinal Players Market Share
        3.2.2 Top 10 Gastrointestinal Players Market Share
        3.2.3 Market Competition Trend
    3.3 Gastrointestinal Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Gastrointestinal Revenue and Market Share by Type (2016-2021)
    4.2 Global Gastrointestinal Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Gastrointestinal Revenue Market Share by Application (2016-2021)
    5.2 Gastrointestinal Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Gastrointestinal Revenue by Type (2016-2026)
    6.2 North America Gastrointestinal Revenue by Application (2016-2026)
    6.3 North America Gastrointestinal Market Size by Country
        6.3.1 North America Gastrointestinal Revenue by Country (2016-2026)
        6.3.2 United States Gastrointestinal Market Size and Forecast (2016-2026)
        6.3.3 Canada Gastrointestinal Market Size and Forecast (2016-2026)
        6.3.4 Mexico Gastrointestinal Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Gastrointestinal Revenue by Type (2016-2026)
    7.2 Europe Gastrointestinal Revenue by Application (2016-2026)
    7.3 Europe Gastrointestinal Market Size by Country
        7.3.1 Europe Gastrointestinal Revenue by Country (2016-2026)
        7.3.2 Germany Gastrointestinal Market Size and Forecast (2016-2026)
        7.3.3 France Gastrointestinal Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Gastrointestinal Market Size and Forecast (2016-2026)
        7.3.5 Russia Gastrointestinal Market Size and Forecast (2016-2026)
        7.3.6 Italy Gastrointestinal Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Gastrointestinal Revenue by Type (2016-2026)
    8.2 Asia-Pacific Gastrointestinal Revenue by Application (2016-2026)
    8.3 Asia-Pacific Gastrointestinal Market Size by Region
        8.3.1 Asia-Pacific Gastrointestinal Revenue by Region (2016-2026)
        8.3.2 China Gastrointestinal Market Size and Forecast (2016-2026)
        8.3.3 Japan Gastrointestinal Market Size and Forecast (2016-2026)
        8.3.4 South Korea Gastrointestinal Market Size and Forecast (2016-2026)
        8.3.5 India Gastrointestinal Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Gastrointestinal Market Size and Forecast (2016-2026)
        8.3.7 Australia Gastrointestinal Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Gastrointestinal Revenue by Type (2016-2026)
    9.2 South America Gastrointestinal Revenue by Application (2016-2026)
    9.3 South America Gastrointestinal Market Size by Country
        9.3.1 South America Gastrointestinal Revenue by Country (2016-2026)
        9.3.2 Brazil Gastrointestinal Market Size and Forecast (2016-2026)
        9.3.3 Argentina Gastrointestinal Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Gastrointestinal Revenue by Type (2016-2026)
    10.2 Middle East & Africa Gastrointestinal Revenue by Application (2016-2026)
    10.3 Middle East & Africa Gastrointestinal Market Size by Country
        10.3.1 Middle East & Africa Gastrointestinal Revenue by Country (2016-2026)
        10.3.2 Turkey Gastrointestinal Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Gastrointestinal Market Size and Forecast (2016-2026)
        10.3.4 UAE Gastrointestinal Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gastrointestinal Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Gastrointestinal Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Gastrointestinal Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Gastrointestinal Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Gastrointestinal Revenue Market Share by Region (2021-2026)
    Table 6. AstraZenec Corporate Information, Head Office, and Major Competitors
    Table 7. AstraZenec Major Business
    Table 8. AstraZenec Gastrointestinal Product and Solutions
    Table 9. AstraZenec Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Sanofi Corporate Information, Head Office, and Major Competitors
    Table 11. Sanofi Major Business
    Table 12. Sanofi Gastrointestinal Product and Solutions
    Table 13. Sanofi Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Bayer Corporate Information, Head Office, and Major Competitors
    Table 15. Bayer Major Business
    Table 16. Bayer Gastrointestinal Product and Solutions
    Table 17. Bayer Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Pfizer Corporate Information, Head Office, and Major Competitors
    Table 19. Pfizer Major Business
    Table 20. Pfizer Gastrointestinal Product and Solutions
    Table 21. Pfizer Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
    Table 23. GlaxoSmithKline Major Business
    Table 24. GlaxoSmithKline Gastrointestinal Product and Solutions
    Table 25. GlaxoSmithKline Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Teva Corporate Information, Head Office, and Major Competitors
    Table 27. Teva Major Business
    Table 28. Teva Gastrointestinal Product and Solutions
    Table 29. Teva Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Zeria（Tillotts） Corporate Information, Head Office, and Major Competitors
    Table 31. Zeria（Tillotts） Major Business
    Table 32. Zeria（Tillotts） Gastrointestinal Product and Solutions
    Table 33. Zeria（Tillotts） Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Perrigo Corporate Information, Head Office, and Major Competitors
    Table 35. Perrigo Major Business
    Table 36. Perrigo Gastrointestinal Product and Solutions
    Table 37. Perrigo Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
    Table 39. Boehringer Ingelheim Major Business
    Table 40. Boehringer Ingelheim Gastrointestinal Product and Solutions
    Table 41. Boehringer Ingelheim Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Purdue Pharma Corporate Information, Head Office, and Major Competitors
    Table 43. Purdue Pharma Major Business
    Table 44. Purdue Pharma Gastrointestinal Product and Solutions
    Table 45. Purdue Pharma Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. C.B. Fleet Corporate Information, Head Office, and Major Competitors
    Table 47. C.B. Fleet Major Business
    Table 48. C.B. Fleet Gastrointestinal Product and Solutions
    Table 49. C.B. Fleet Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Abbott Corporate Information, Head Office, and Major Competitors
    Table 51. Abbott Major Business
    Table 52. Abbott Gastrointestinal Product and Solutions
    Table 53. Abbott Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Jiangzhong Corporate Information, Head Office, and Major Competitors
    Table 55. Jiangzhong Major Business
    Table 56. Jiangzhong Gastrointestinal Product and Solutions
    Table 57. Jiangzhong Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Xian-Janssen Corporate Information, Head Office, and Major Competitors
    Table 59. Xian-Janssen Major Business
    Table 60. Xian-Janssen Gastrointestinal Product and Solutions
    Table 61. Xian-Janssen Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 62. Global Gastrointestinal Revenue (USD Million) by Players (2019-2021)
    Table 63. Global Gastrointestinal Revenue Share by Players (2019-2021)
    Table 64. Breakdown of Gastrointestinal by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 65. Gastrointestinal Players Head Office, Products and Services Provided
    Table 66. Gastrointestinal Mergers & Acquisitions in the Past Five Years
    Table 67. Gastrointestinal New Entrants and Expansion Plans
    Table 68. Global Gastrointestinal Revenue (USD Million) by Type (2016-2021)
    Table 69. Global Gastrointestinal Revenue Share by Type (2016-2021)
    Table 70. Global Gastrointestinal Revenue Forecast by Type (2021-2026)
    Table 71. Global Gastrointestinal Revenue by Application (2016-2021)
    Table 72. Global Gastrointestinal Revenue Forecast by Application (2021-2026)
    Table 73. North America Gastrointestinal Revenue by Type (2016-2021) & (USD Million)
    Table 74. North America Gastrointestinal Revenue by Type (2021-2026) & (USD Million)
    Table 75. North America Gastrointestinal Revenue by Application (2016-2021) & (USD Million)
    Table 76. North America Gastrointestinal Revenue by Application (2021-2026) & (USD Million)
    Table 77. North America Gastrointestinal Revenue by Country (2016-2021) & (USD Million)
    Table 78. North America Gastrointestinal Revenue by Country (2021-2026) & (USD Million)
    Table 79. Europe Gastrointestinal Revenue by Type (2016-2021) & (USD Million)
    Table 80. Europe Gastrointestinal Revenue by Type (2021-2026) & (USD Million)
    Table 81. Europe Gastrointestinal Revenue by Application (2016-2021) & (USD Million)
    Table 82. Europe Gastrointestinal Revenue by Application (2021-2026) & (USD Million)
    Table 83. Europe Gastrointestinal Revenue by Country (2016-2021) & (USD Million)
    Table 84. Europe Gastrointestinal Revenue by Country (2021-2026) & (USD Million)
    Table 85. Asia-Pacific Gastrointestinal Revenue by Type (2016-2021) & (USD Million)
    Table 86. Asia-Pacific Gastrointestinal Revenue by Type (2021-2026) & (USD Million)
    Table 87. Asia-Pacific Gastrointestinal Revenue by Application (2016-2021) & (USD Million)
    Table 88. Asia-Pacific Gastrointestinal Revenue by Application (2021-2026) & (USD Million)
    Table 89. Asia-Pacific Gastrointestinal Revenue by Region (2016-2021) & (USD Million)
    Table 90. Asia-Pacific Gastrointestinal Revenue by Region (2021-2026) & (USD Million)
    Table 91. South America Gastrointestinal Revenue by Type (2016-2021) & (USD Million)
    Table 92. South America Gastrointestinal Revenue by Type (2021-2026) & (USD Million)
    Table 93. South America Gastrointestinal Revenue by Application (2016-2021) & (USD Million)
    Table 94. South America Gastrointestinal Revenue by Application (2021-2026) & (USD Million)
    Table 95. South America Gastrointestinal Revenue by Country (2016-2021) & (USD Million)
    Table 96. South America Gastrointestinal Revenue by Country (2021-2026) & (USD Million)
    Table 97. Middle East & Africa Gastrointestinal Revenue by Type (2016-2021) & (USD Million)
    Table 98. Middle East & Africa Gastrointestinal Revenue by Type (2021-2026) & (USD Million)
    Table 99. Middle East & Africa Gastrointestinal Revenue by Application (2016-2021) & (USD Million)
    Table 100. Middle East & Africa Gastrointestinal Revenue by Application (2021-2026) & (USD Million)
    Table 101. Middle East & Africa Gastrointestinal Revenue by Country (2016-2021) & (USD Million)
    Table 102. Middle East & Africa Gastrointestinal Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Gastrointestinal Picture
    Figure 2. Global Gastrointestinal Revenue Market Share by Type in 2020
    Figure 3. Prescription Gastrointestinal Drug
    Figure 4. OTC Gastrointestinal Drug
    Figure 5. Gastrointestinal Revenue Market Share by Application in 2020
    Figure 6. Chronic Gastritis Picture
    Figure 7. Functional Dyspepsia Picture
    Figure 8. Peptic Ulcer Picture
    Figure 9. Acute Gastroenteritis Picture
    Figure 10. Others Picture
    Figure 11. Global Gastrointestinal Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 12. Global Gastrointestinal Revenue and Forecast (2016-2026) & (USD Million)
    Figure 13. Global Gastrointestinal Revenue Market Share by Region (2016-2026)
    Figure 14. Global Gastrointestinal Revenue Market Share by Region in 2020
    Figure 15. North America Gastrointestinal Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. Europe Gastrointestinal Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Asia-Pacific Gastrointestinal Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. South America Gastrointestinal Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Middle East and Africa Gastrointestinal Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. Gastrointestinal Market Drivers
    Figure 21. Gastrointestinal Market Restraints
    Figure 22. Gastrointestinal Market Trends
    Figure 23. AstraZenec Recent Developments and Future Plans
    Figure 24. Sanofi Recent Developments and Future Plans
    Figure 25. Bayer Recent Developments and Future Plans
    Figure 26. Pfizer Recent Developments and Future Plans
    Figure 27. GlaxoSmithKline Recent Developments and Future Plans
    Figure 28. Teva Recent Developments and Future Plans
    Figure 29. Zeria（Tillotts） Recent Developments and Future Plans
    Figure 30. Perrigo Recent Developments and Future Plans
    Figure 31. Boehringer Ingelheim Recent Developments and Future Plans
    Figure 32. Purdue Pharma Recent Developments and Future Plans
    Figure 33. C.B. Fleet Recent Developments and Future Plans
    Figure 34. Abbott Recent Developments and Future Plans
    Figure 35. Jiangzhong Recent Developments and Future Plans
    Figure 36. Xian-Janssen Recent Developments and Future Plans
    Figure 37. Global Gastrointestinal Revenue Share by Players in 2020
    Figure 38. Gastrointestinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 39. Global Top 3 Players Gastrointestinal Revenue Market Share in 2020
    Figure 40. Global Top 10 Players Gastrointestinal Revenue Market Share in 2020
    Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 42. Global Gastrointestinal Revenue Share by Type in 2020
    Figure 43. Global Gastrointestinal Market Share Forecast by Type (2021-2026)
    Figure 44. Global Gastrointestinal Revenue Share by Application in 2020
    Figure 45. Global Gastrointestinal Market Share Forecast by Application (2021-2026)
    Figure 46. North America Gastrointestinal Sales Market Share by Type (2016-2026)
    Figure 47. North America Gastrointestinal Sales Market Share by Application (2016-2026)
    Figure 48. North America Gastrointestinal Revenue Market Share by Country (2016-2026)
    Figure 49. United States Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Canada Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Mexico Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Europe Gastrointestinal Sales Market Share by Type (2016-2026)
    Figure 53. Europe Gastrointestinal Sales Market Share by Application (2016-2026)
    Figure 54. Europe Gastrointestinal Revenue Market Share by Country (2016-2026)
    Figure 55. Germany Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. France Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. United Kingdom Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Russia Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Italy Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Asia-Pacific Gastrointestinal Sales Market Share by Type (2016-2026)
    Figure 61. Asia-Pacific Gastrointestinal Sales Market Share by Application (2016-2026)
    Figure 62. Asia-Pacific Gastrointestinal Revenue Market Share by Region (2016-2026)
    Figure 63. China Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Japan Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. South Korea Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. India Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Southeast Asia Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Australia Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. South America Gastrointestinal Sales Market Share by Type (2016-2026)
    Figure 70. South America Gastrointestinal Sales Market Share by Application (2016-2026)
    Figure 71. South America Gastrointestinal Revenue Market Share by Country (2016-2026)
    Figure 72. Brazil Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Argentina Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Middle East and Africa Gastrointestinal Sales Market Share by Type (2016-2026)
    Figure 75. Middle East and Africa Gastrointestinal Sales Market Share by Application (2016-2026)
    Figure 76. Middle East and Africa Gastrointestinal Revenue Market Share by Country (2016-2026)
    Figure 77. Turkey Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Saudi Arabia Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. UAE Gastrointestinal Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Companies Mentioned

AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen